Drug firm Venus Remedies today said its net profit rose by 4.5 per cent to Rs 11.5 crore for the second quarter ended September 30, 2010.
The company had a net profit of Rs 11 crore in the same period corresponding fiscal.
Total income of the company rose to Rs 85.8 crore for the second quarter ended September 30, compared to Rs 75.6 crore in the same period previous fiscal, Venus Remedies aid in a filing to the Bombay Stock Exchange (BSE).
Shares of Venus Remedies today closed at Rs 312.40 on the BSE, up 0.42 per cent from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app